Breaking News: SeroScience’s anti-PEG antibody and complement assays in plasma help to assess the risk of major allergic reactions to PEGylated nanoparticle-based vaccines, such as Pfizer's and Moderna's currently applied vaccines against SARS-CoV-2.
Toxicology Testing Services with Unique Expertise in Predicting and Preventing Undesirable Immune Responses to IV Administered Nanobiopharmaceuticals.
At SeroScience©, we harness a network of international GLP compliant laboratories and world leading experts to tackle immune-related barriers to drug development at the R&D, Pre-Clinical, Clinical, and Regulatory Reporting levels.
Click below to learn more about our expert services, or use the contact form to set up a consultation.
Case Studies
Gene Therapy Dosing Protocol
Played key role in the development of an FDA approved dosing protocol for the flagship product of a leading gene therapy developer struggling with issues surrounding infusion related hypersensitivity reactions to their lipid based delivery platform.
Medical Device R&D
Led tailored R&D program for a Fortune 500 medical device company after a toxicity assessment led to ground-breaking discoveries surrounding fundamental causes of hypersensitivity reactions to one of their main medical device product lines.
Immunotoxicology Consulting
Provided expert testimony to senior management at a large pharma firm which dissuaded them from killing the program of a future block-buster drug in early pre-clinical trials due to a study they had conducted which showed severe toxicity in rabbits along a pathway irrelevant to human toxicity.